Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 193
Filter
1.
J Infect Dis ; 220(4): 657-665, 2019 07 19.
Article in English | MEDLINE | ID: mdl-31100118

ABSTRACT

Glucan is the major cell wall component of Pneumocystis cysts. In the current study, we have characterized Pneumocystis Bgl2 (EC 3.2.1.58), an enzyme with glucanosyltransferase and ß-1,3 endoglucanase activity in other fungi. Pneumocystis murina, Pneumocystis carinii, and Pneumocystis jirovecii bgl2 complementary DNA sequences encode proteins of 437, 447, and 408 amino acids, respectively. Recombinant P. murina Bgl2 expressed in COS-1 cells demonstrated ß-glucanase activity, as shown by degradation of the cell wall of Pneumocystis cysts. It also cleaved reduced laminaripentaose and transferred oligosaccharides, resulting in polymers of 6 and 7 glucan residues, demonstrating glucanosyltransferase activity. Surprisingly, confocal immunofluorescence analysis of P. murina-infected mouse lung sections using an antibody against recombinant Bgl2 showed that the native protein is localized primarily to the trophic form of Pneumocystis in both untreated mice and mice treated with caspofungin, an antifungal drug that inhibits ß-1,3-glucan synthase. Thus, like other fungi, Bgl2 of Pneumocystis has both endoglucanase and glucanosyltransferase activities. Given that it is expressed primarily in trophic forms, further studies are needed to better understand its role in the biology of Pneumocystis.


Subject(s)
Antifungal Agents/pharmacology , Caspofungin/pharmacology , Glucan Endo-1,3-beta-D-Glucosidase/metabolism , Pneumocystis/enzymology , Amino Acid Sequence , Animals , CD40 Ligand/genetics , COS Cells , Cell Wall/enzymology , Chlorocebus aethiops , Glucan Endo-1,3-beta-D-Glucosidase/antagonists & inhibitors , Glucan Endo-1,3-beta-D-Glucosidase/genetics , Glucans/metabolism , Lung/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Pneumocystis/genetics , Pneumocystis/immunology , Pneumonia, Pneumocystis/immunology , Recombinant Proteins , Sequence Alignment
2.
Vaccine ; 35(4): 672-679, 2017 01 23.
Article in English | MEDLINE | ID: mdl-28012778

ABSTRACT

RATIONALE: Pneumocystis pneumonia is a major cause of morbidity and mortality in HIV-infected subjects, cancer patients undergoing chemotherapy and solid organ transplant recipients. No vaccine is currently available. By chemical labeling coupled with proteomic approach, we have identified a putative surface protein (SPD1, Broad Institute gene accession number PNEG_01848) derived from single suspended P. murina cysts. SPD1 was expressed in an insect cell line and tested for vaccine development. METHODS: Mice were immunized with SPD1 plus adjuvant MF-59 by subcutaneous injection. Three weeks after the last immunization, CD4+ cells were depleted with anti-CD4 antibody GK1.5. The mice were then challenged with 2×105Pneumocystis organisms. Mice were sacrificed at 4 and 6weeks after PC challenge. Spleen/lung cells and serum were harvested. B cells and memory B cells were assessed via flow cytometry. Specific Pneumocystis IgG antibody was measured by ELISA before and after challenge. Infection burden was measured as real-time PCR for P. murina rRNA. RESULTS: Normal mice infected with Pneumocystis mounted a serum IgG antibody response to SPD1. Serum from rhesus macaques exposed to Pneumocystis showed a similar serum IgG response to purified SPD1. SPD1 immunization increased B cell and memory B cell absolute cell counts in CD4-depleted Balb/c mice post Pneumocystis challenge in spleen and lung. Immunization with SPD1 significantly increased specific Pneumocystis IgG antibody production before and after challenge. Mice immunized with SPD1 showed significantly decreased P. murina copy number compared with mice that did not receive SPD1 at 6weeks after challenge. CONCLUSION: Immunization with SPD1 provides protective efficacy against P. murina infection. SPD1 protection against Pneumocystis challenge is associated with enhanced memory B cell production and higher anti-Pneumocystis IgG antibody production. SPD1 is a potential vaccine candidate to prevent or treat pulmonary infection with Pneumocystis.


Subject(s)
Antibodies, Fungal/blood , B-Lymphocytes/immunology , Fungal Vaccines/immunology , Membrane Proteins/immunology , Peptide Hydrolases/immunology , Pneumocystis/immunology , Pneumonia, Pneumocystis/prevention & control , Animals , Antibody Formation , Antigens, Fungal/genetics , Antigens, Fungal/immunology , Colony Count, Microbial , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Fungal Vaccines/administration & dosage , Fungal Vaccines/genetics , Lung/microbiology , Macaca mulatta , Membrane Proteins/genetics , Mice, Inbred BALB C , Peptide Hydrolases/genetics , Pneumocystis/enzymology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology
3.
J Infect Dis ; 211(5): 719-28, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25231017

ABSTRACT

ß-1,3-glucan is a major cell wall component of Pneumocystis cysts. We have characterized endo-ß-1,3-glucanase (Eng) from 3 species of Pneumocystis. The gene eng is a single-copy gene that encodes a protein containing 786 amino acids in P. carinii and P. murina, and 788 amino acids in P. jirovecii, including a signal peptide for the former 2 but not the latter. Recombinant Eng expressed in Escherichia coli was able to solubilize the major surface glycoprotein of Pneumocystis, thus potentially facilitating switching of the expressed major surface glycoprotein (Msg) variant. Confocal immunofluorescence analysis of P. murina-infected mouse lung sections localized Eng exclusively to the cyst form of Pneumocystis. No Eng was detected after mice were treated with caspofungin, a ß-1,3-glucan synthase inhibitor that is known to reduce the number of cysts. Thus, Eng is a cyst-specific protein that may play a role in Msg variant expression in Pneumocystis.


Subject(s)
Gene Expression Regulation, Fungal , Glucan Endo-1,3-beta-D-Glucosidase/biosynthesis , Pneumocystis/enzymology , Spores, Fungal/enzymology , Animals , Escherichia coli/genetics , Gene Expression , Glucan Endo-1,3-beta-D-Glucosidase/genetics , Lung/microbiology , Lung/pathology , Mice , Microscopy, Confocal , Microscopy, Fluorescence , Pneumocystis/genetics , Protein Sorting Signals/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Spores, Fungal/genetics
4.
Rev. bras. parasitol. vet ; 23(4): 534-538, Oct-Dec/2014. tab
Article in English | LILACS | ID: lil-731264

ABSTRACT

With the aim of studying the endoparasite fauna of horses from the Formiga city, located in center-west region of the state of Minas Gerais, 25 animals that were naturally infected with helminths were evaluated. By means of parasitological necropsies, different endoparasites were found. The subfamily Cyathostominae presented the highest incidence, followed by Trichostrongylus axei, Oxyuris equi, Triodontophorus serratus, Strongyloides westeri, Strongylus edentatus, Habronema muscae, Parascaris equorum, Probstmayria vivipara, Strongylus vulgaris, Gasterophilus nasalis, Anoplocephala magna and Anoplocephala perfoliata. In the present study, if the species Probstmayria vivipara was not considered in the prevalence, the frequency of Cyathostominae was equivalent to 94.85%. The results obtained in this study allowed us to detect and identify different species of helminths in horses, and confirmed the high incidence of nematodes belonging to the subfamily Cyathostominae in the center-west region of Minas Gerais.


Com o objetivo de estudar a fauna de endoparasitas de equinos da Região Centro-Oeste do Estado de Minas Gerais, 25 animais naturalmente infectados por helmintos foram avaliados. Por meio de necropsias parasitológicas, diferentes endoparasitas foram identificados. A sub - família Cyathostominae apresentou maior incidência, seguido por Trichostrongylus axei, Oxyuris equi, Triodontophorus serratus, Strongyloides westeri, Strongylus edentatus, Habronema muscae, Parascaris equorum, Probstmayria vivipara, Strongylus vulgaris, Gasterophilus nasalis, Anoplocephala magna e Anoplocephala perfoliata. No presente estudo, se não for considerada a espécie Probstmayria vivipara na prevalência, a frequência de Cyathostominae é equivalente a 94,85%. Os resultados obtidos neste estudo, permitiu detectar e identificar diferentes espécies de helmintos em equinos, bem como confirmar a elevada incidência de nematódeos pertencentes à sub-família Cyathostominae na Região Centro-Oeste de Minas Gerais.


Subject(s)
Humans , Alcohol Oxidoreductases/antagonists & inhibitors , Pyrimidines/chemistry , Quantitative Structure-Activity Relationship , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Opportunistic Infections/drug therapy , Pneumocystis/enzymology , Pyrimidines/pharmacology , Regression Analysis
5.
J Infect Dis ; 202(12): 1920-9, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-21050123

ABSTRACT

The life cycle of Pneumocystis, which causes life-threatening pneumonia in immunosuppressed patients, remains poorly defined. In the present study, we have identified and characterized an orthologue of dmc1, a gene specific for meiotic recombination in yeast, in 3 species of Pneumocystis. dmc1 is a single-copy gene that is transcribed as ∼1.2-kb messenger RNA, which encodes a protein of 336-337 amino acids. Pneumocystis Dmc1 was 61%-70% identical to those from yeast. Confocal microscopy results indicated that the expression of Dmc1 is primarily confined to the cyst form of Pneumocystis. By sequence analysis of 2 single-copy regions of the human Pneumocystis jirovecii genome, we can infer multiple recombination events, which are consistent with meiotic recombination in this primarily haploid organism. Taken together, these studies support the occurrence of a sexual phase in the life cycle of Pneumocystis.


Subject(s)
Fungal Proteins/genetics , Fungal Proteins/metabolism , Pneumocystis/enzymology , Recombinases/genetics , Recombinases/metabolism , Amino Acid Sequence , Base Sequence , Gene Dosage , Gene Expression Profiling , Molecular Sequence Data , RNA, Fungal/biosynthesis , RNA, Messenger/biosynthesis , Recombination, Genetic , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Transcription, Genetic
6.
Eukaryot Cell ; 8(4): 483-6, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19168759

ABSTRACT

Trimethoprim, an antifolate commonly prescribed in combination with sulfamethoxazole, potently inhibits several prokaryotic species of dihydrofolate reductase (DHFR). However, several eukaryotic pathogenic organisms are resistant to trimethoprim, preventing its effective use as a therapeutic for those infections. We have been building a program to reengineer trimethoprim to more potently and selectively inhibit eukaryotic species of DHFR as a viable strategy for new drug discovery targeting several opportunistic pathogens. We have developed a series of compounds that exhibit potent and selective inhibition of DHFR from the parasitic protozoa Cryptosporidium and Toxoplasma as well as the fungus Candida glabrata. A comparison of the structures of DHFR from the fungal species Candida glabrata and Pneumocystis suggests that the compounds may also potently inhibit Pneumocystis DHFR.


Subject(s)
Folic Acid Antagonists/pharmacology , Fungal Proteins/chemistry , Opportunistic Infections/drug therapy , Protozoan Proteins/chemistry , Tetrahydrofolate Dehydrogenase/chemistry , Trimethoprim/pharmacology , Amino Acid Sequence , Animals , Candida glabrata/chemistry , Candida glabrata/enzymology , Drug Design , Folic Acid Antagonists/chemistry , Fungal Proteins/antagonists & inhibitors , Fungal Proteins/metabolism , Humans , Molecular Sequence Data , Opportunistic Infections/microbiology , Opportunistic Infections/parasitology , Pneumocystis/chemistry , Pneumocystis/enzymology , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/metabolism , Sequence Alignment , Structure-Activity Relationship , Tetrahydrofolate Dehydrogenase/metabolism , Toxoplasma/chemistry , Toxoplasma/enzymology , Trimethoprim/chemistry
8.
J Clin Microbiol ; 43(3): 1443-4, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15750128

ABSTRACT

Dihydropteroate synthase (DHPS) gene mutations have raised concerns about emerging sulfonamide resistance in Pneumocystis jirovecii. DHPS and dihydrofolate reductase (DHFR) gene products were amplified in clinical specimens from South African patients. One of 53 DHPS genes sequenced contained the double mutation Thr55Ala Pro57Ser. DHFR gene mutations detected were Ala67Val and the new mutations Arg59Gly and C278T.


Subject(s)
Dihydropteroate Synthase/genetics , Mutation , Pneumocystis/enzymology , Pneumocystis/genetics , Tetrahydrofolate Dehydrogenase/genetics , Humans
9.
Int J Antimicrob Agents ; 22(5): 516-20, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14602371

ABSTRACT

The aim of this study was to evaluate the frequency of mutations of the P. jiroveci dihydropteroate synthase (DHPS) gene in an immunocompromised Portuguese population and to investigate the possible association between DHPS mutations and sulpha exposure. In the studied population, DHPS gene mutations were not significantly more frequent in patients exposed to sulpha drugs compared with patients not exposed (P=0.390). The results of this study suggest that DHPS gene mutations are frequent in the Portuguese immunocompromised population but do not seem associated with previous sulpha exposure. These results are consistent with the possibility of an incidental acquisition and transmission of P. jiroveci mutant types, either by person to person transmission or from an environmental source.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Dihydropteroate Synthase/genetics , Pneumocystis/enzymology , Pneumonia, Pneumocystis/genetics , Adolescent , Adult , Bronchoalveolar Lavage Fluid/microbiology , Child , Female , Humans , Immunocompromised Host , Infant , Male , Middle Aged , Mutation , Pneumocystis/drug effects , Pneumonia, Pneumocystis/drug therapy , Portugal
10.
FEBS Lett ; 551(1-3): 139-46, 2003 Sep 11.
Article in English | MEDLINE | ID: mdl-12965219

ABSTRACT

Mitogen-activated protein kinase (MAPK) pathways transfer environmental signals into intracellular events such as proliferation and differentiation. Fungi utilize a specific pheromone-induced MAPK pathway to regulate conjugation, formation of an ascus, and entry into meiosis. We have previously identified a MAPK, PCM, from the fungal opportunist Pneumocystis, responsible for causing severe pneumonia in patients with AIDS. In order to gain insight into the function of PCM, we expressed it in Saccharomyces cerevisiae deficient in pheromone signaling and tested activation and inhibition of this MAPK pathway. PCM restored pheromone signaling in S. cerevisiae fus3Delta kss1Delta mutants with alpha-factor pheromone (six-fold increase) and was not activated by osmotic stress. Signaling through this pathway decreased 2.5-fold with 10 microM U0126, and was unaffected with SB203580. We evaluated the conditions for native PCM kinase activity isolated from Pneumocystis carinii organisms and found that 0.1 mM MgCl2, pH 6.5, temperature 30-35 degrees C, and 10 microM ATP were optimal. The activity of PCM is significantly elevated in P. carinii trophic forms compared to cysts, implicating a role for PCM in the life cycle transition of P. carinii from trophic forms to cysts.


Subject(s)
Mitogen-Activated Protein Kinases/physiology , Pneumocystis/enzymology , Butadienes/pharmacology , Enzyme Inhibitors/pharmacology , Genetic Complementation Test , MAP Kinase Signaling System , Mating Factor , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/genetics , Nitriles/pharmacology , Peptides/pharmacology , Pneumocystis/genetics , Pneumocystis/growth & development , RNA, Fungal/metabolism
11.
J Infect Dis ; 188(7): 1017-23, 2003 Oct 01.
Article in English | MEDLINE | ID: mdl-14513422

ABSTRACT

To investigate the possible association between different prophylactic sulfa drugs and the genotype of the Pneumocystis jiroveci dihydropteroate synthase (DHPS) gene, we examined DHPS polymorphisms in clinical specimens from 158 immunosuppressed patients (38 HIV-negative and 120 HIV-positive), using polymerase chain reaction-single-strand conformation polymorphism. Fifty-seven (36.1%) of 158 patients were infected with a mutant DHPS genotype. All patients who developed P. jiroveci pneumonia (PcP) while receiving pyrimethamine/sulfadoxine (PM/SD) prophylaxis (n=14) had a strain harboring DHPS with an amino acid change at position 57 (Pro-->Ser). This mutation was only present in 20 (14%) of 144 patients not receiving prophylaxis (P<.001). Hospitalization in a specific hospital was an independent risk factor for having P. jiroveci harboring the same DHPS mutation, which indirectly supports that interhuman transmission may affect the dissemination of the mutant strains.


Subject(s)
Anti-Bacterial Agents , Antibiotic Prophylaxis/methods , Dihydropteroate Synthase/genetics , Drug Therapy, Combination/pharmacology , HIV Infections/microbiology , HIV-1 , Pneumocystis Infections/microbiology , Pneumocystis/enzymology , Pyrimethamine/pharmacology , Sulfadoxine/pharmacology , Adolescent , Adult , Aged , Alleles , Bronchoalveolar Lavage Fluid/microbiology , Child , Child, Preschool , Drug Combinations , Female , HIV Infections/immunology , Humans , Immunocompromised Host , Male , Middle Aged , Pneumocystis/genetics , Pneumocystis Infections/immunology , Pneumocystis Infections/prevention & control , Pneumocystis Infections/virology , Point Mutation , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational
12.
FEBS Lett ; 548(1-3): 59-68, 2003 Jul 31.
Article in English | MEDLINE | ID: mdl-12885408

ABSTRACT

Pneumocystis pneumonia remains the most common AIDS-defining opportunistic infection in people with HIV. The process by which Pneumocystis carinii constructs its cell wall is not well known, although recent studies reveal that molecules such as beta-1-3-glucan synthetase (GSC1) and environmental pH-responsive genes such as PHR1 are important for cell-wall integrity. In closely related fungi, a specific mitogen-activated protein kinase (MAPK) cascade regulates cell-wall assembly in response to elevated temperature. The upstream mitogen-activated protein kinase kinase kinase (MAPKKK, or MEKK), BCK1, is an essential component in this pathway for maintaining cell-wall integrity and preventing fungal cell lysis. We have identified a P. carinii MEKK gene and have expressed it in Saccharomyces cerevisiae to gain insights into its function. The P. carinii MEKK, PCBCK1, corrects the temperature-sensitive cell lysis defect of bck1Delta yeast. Further, at elevated temperature PCBCK1 restored the signaling defect in bck1Delta yeast to maintain expression of the temperature-inducible beta-1-3-glucan synthetase gene, FKS2. PCBCK1, as a functional kinase, is capable of autophosphorylation and substrate phosphorylation. Since glucan machinery is not present in mammals, a better understanding of this pathway in P. carinii might aid in the development of novel medications which interfere with the integrity of the Pneumocystis cell wall.


Subject(s)
Cell Wall/metabolism , Glucosyltransferases , MAP Kinase Signaling System/physiology , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinase Kinases/physiology , Pneumocystis/enzymology , Saccharomyces cerevisiae Proteins , Base Sequence , Cloning, Molecular , Conserved Sequence , Genes, Fungal/genetics , MAP Kinase Kinase Kinases , Membrane Proteins/metabolism , Mitogen-Activated Protein Kinase Kinases/genetics , Molecular Sequence Data , Mutation , Saccharomyces cerevisiae/genetics , Sequence Alignment , Temperature
13.
Gene ; 310: 175-83, 2003 May 22.
Article in English | MEDLINE | ID: mdl-12801645

ABSTRACT

We have characterized the thioredoxin reductase (trr1) genes from Pneumocystis carinii and Pneumocystis jiroveci, and have demonstrated that multiple copies of an approximately 500 base pair fragment of the trr1 gene are present in P. carinii, but not in P. jiroveci. Thioredoxin reductases encoded by the full-length genes have predicted molecular weights of approximately 35,000 and show high homology to yeast Trr1. An NADPH-binding domain with a putative redox active site CAVC as well as an flavin-adenine dinucleotide-binding domain are highly conserved in both proteins, which were 85% identical. The multicopy trr1 gene fragments in P. carinii are not transcribed or expressed. Duplication of the gene fragment likely occurred in conjunction with duplication of the kexin homologue, protease-1, which is located immediately upstream of the trr1 gene. Thioredoxin reductase, an enzyme implicated in the growth, survival and pathogenicity of certain microbes, could be a potential target for therapeutic intervention in Pneumocystis infection.


Subject(s)
Ascomycota/genetics , Pneumocystis/genetics , Thioredoxin-Disulfide Reductase/genetics , Amino Acid Sequence , Ascomycota/enzymology , Base Sequence , Blotting, Northern , Blotting, Southern , DNA, Complementary/chemistry , DNA, Complementary/genetics , DNA, Fungal/chemistry , DNA, Fungal/genetics , Fungal Proteins/genetics , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Fungal , Molecular Sequence Data , Pneumocystis/enzymology , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Schizosaccharomyces/enzymology , Schizosaccharomyces/genetics , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Thioredoxin-Disulfide Reductase/metabolism
14.
J Med Chem ; 46(9): 1726-36, 2003 Apr 24.
Article in English | MEDLINE | ID: mdl-12699390

ABSTRACT

As part of an ongoing effort to discover novel small-molecule antifolates combining the enzyme-binding species selectivity of trimethoprim (TMP) with the potency of piritrexim (PTX), 10 previously unreported 2,4-diamino-5-(2'-methoxy-5'-substituted)benzylpyrimidines (2-11) containing a carboxyl group at the distal end of the 5'-substituent were synthesized and tested as inhibitors of dihydrofolate reductase (DHFR) from Pneumocystis carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium (Ma), three of the opportunistic pathogens frequently responsible for life-threatening illness in people with impaired immune systems as a result of HIV infection or immunosuppressive chemotherapy. The selectivity index of DHFR inhibition was evaluated by comparing the potency of each compound against the parasite enzymes with its potency against rat liver DHFR. 2,4-Diamino-5-[5'-(5-carboxy-1-pentynyl)-2'-methoxybenzyl]pyrimidine (3) inhibited Pc DHFR with a selectivity index of 79 and was 430 times more potent than TMP. 2,4-Diamino-5-[5'-(4-carboxy-1-butynyl)-2'-methoxybenzyl]pyrimidine (2), with one less carbon than 3 in the side chain, had a selectivity index of 910 against Ma DHFR and was 43 times more potent than TMP. 2,4-Diamino-5-[5'-(5-carboxypentyl)-2'-methoxybenzyl]pyrimidine (6) had a selectivity index of 490 against Tg DHFR and was 320 times more potent than TMP. 2,4-Diamino-5-[5'-(6-carboxy-1-hexynyl)-2'-methoxybenzyl]pyrimidine (4), with one more carbon than 3, was less potent against all three of the parasite enzymes than either 3 or 6 and also had a lower selectivity index than 3 against the Pc enzyme. However, 4 was the only member of the series with a selectivity index of >300 against both Tg and Ma DHFR. Given that PTX is at least 10 times more potent against rat DHFR than against P. carinii or T. gondii DHFR and that the selectivity index of several of the compounds matches or exceeds that of TMP as well as PTX, our results suggest that it may be possible to develop clinically useful nonclassical antifolates that are both potent and selective against the major opportunistic pathogens of AIDS.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , AIDS-Related Opportunistic Infections/parasitology , Benzyl Compounds/chemical synthesis , Folic Acid Antagonists/chemical synthesis , Pyrimidines/chemical synthesis , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Benzyl Compounds/chemistry , Folic Acid Antagonists/chemistry , Liver/enzymology , Magnetic Resonance Spectroscopy , Mycobacterium avium/enzymology , Pneumocystis/enzymology , Pyrimidines/chemistry , Rats , Species Specificity , Structure-Activity Relationship , Tetrahydrofolate Dehydrogenase/chemistry , Toxoplasma/enzymology
15.
Am J Respir Cell Mol Biol ; 29(2): 232-8, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12606318

ABSTRACT

Pneumocystis carinii (PC) causes severe pneumonia in immunocompromised patients. PC is intrinsically resistant to treatment with azole antifungal medications. The enzyme lanosterol 14 alpha-demethylase (Erg11) is the target for azole antifungals. We cloned PCERG11 and compared its sequence to Erg11 proteins present in azole-resistant organisms, and performed chromosomal and Northern blot analysis for PCERG11. Of 13 potential sites which could confer resistance to azoles, two were identical to azole-resistant Candida. By site-directed mutagenesis we changed these two sites in PCERG11 to those present in azole-sensitive Candida to generate PCERG11-SDM (E113D, T125K). We tested the susceptibility of ERG11 deletion strains of Saccharomyces cerevisiae (SC) expressing PCERG11, PCERG11-SDM, and wild-type SCERG11 to three azole antifungals: fluconazole, itraconazole, and voriconazole. PCERG11 required a 2.2-fold higher dose of voriconazole and 3.5-fold higher dose of fluconazole than SCERG11 for a 50% reduction in growth. No difference was observed in the sensitivity to itraconazole. PCERG11-SDM has increased sensitivity to fluconazole and voriconazole, but not itraconazole. We believe that the molecular structure of the lanosterol 14 alpha-demethylase encoded by PCERG11 confers inherent resistance to azole antifungals and plays an integral part in the overall resistance of this PC to azole therapy.


Subject(s)
Cytochrome P-450 Enzyme System/chemistry , Cytochrome P-450 Enzyme System/genetics , Oxidoreductases/chemistry , Oxidoreductases/genetics , Pneumocystis/enzymology , Amino Acid Sequence , Animals , Antifungal Agents/pharmacology , Base Sequence , Blotting, Northern , Candida/metabolism , Chromosome Mapping , Cloning, Molecular , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Fluconazole/pharmacology , Gene Deletion , Immunoblotting , Itraconazole/pharmacology , Lung/microbiology , Lung/pathology , Molecular Sequence Data , Mutagenesis, Site-Directed , Polymerase Chain Reaction , Protein Biosynthesis , Pyrimidines/pharmacology , RNA, Messenger/metabolism , RNA, Ribosomal/metabolism , Rats , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Sequence Homology, Amino Acid , Sterol 14-Demethylase , Triazoles/pharmacology , Voriconazole
16.
J Mol Graph Model ; 21(5): 391-419, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12543137

ABSTRACT

A data set of 345 dihydrofolate reductase inhibitors was used to build QSAR models that correlate chemical structure and inhibition potency for three types of dihydrofolate reductase (DHFR): rat liver (rl), Pneumocystis carinii (pc), and Toxoplasma gondii (tg). Quantitative models were built using subsets of molecular structure descriptors being analyzed by computational neural networks. Neural network models were able to accurately predict log IC(50) values for the three types of DHFR to within +/-0.65 log units (data sets ranged approximately 5.5 log units) of the experimentally determined values. Classification models were also constructed using linear discriminant analysis to identify compounds as selective or nonselective inhibitors of bacterial DHFR (pcDHFR and tgDHFR) relative to mammalian DHFR (rlDHFR). A leave-N-out training procedure was used to add robustness to the models and to prove that consistent results could be obtained using different training and prediction set splits. The best linear discriminant analysis (LDA) models were able to correctly predict DHFR selectivity for approximately 70% of the external prediction set compounds. A set of new nitrogen and oxygen-specific descriptors were developed especially for this data set to better encode structural features, which are believed to directly influence DHFR inhibition and selectivity.


Subject(s)
Computer Simulation , Enzyme Inhibitors/chemistry , Folic Acid Antagonists/chemistry , Neural Networks, Computer , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Discriminant Analysis , Fungal Proteins/chemistry , Humans , Molecular Structure , Pneumocystis/enzymology , Protozoan Proteins/chemistry , Quantitative Structure-Activity Relationship , Rats , Statistics as Topic , Tetrahydrofolate Dehydrogenase/chemistry , Toxoplasma/enzymology
17.
Bioorg Med Chem ; 11(1): 59-67, 2003 Jan 02.
Article in English | MEDLINE | ID: mdl-12467708

ABSTRACT

A concise new route allowing easy access to five previously unreported 2,4-diamino-6-(substituted benzyl)pyrido[2,3-d]pyrimidines (2a-e) was developed, involving condensation of 2,4-dipivaloylamino-5-bromopyrido[2,3-d]pyrimidine (6) with an organozinc halide in the presence of a catalytic amount of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II).CH(2)Cl(2), followed by removal of the pivaloyl groups with base. Also prepared via a scheme based on the Taylor ring expansion/ring annulation synthesis were three heretofore undescribed 2,4-diamino-5-(substituted benzyl)-7H-pyrrolo[2,3-d]pyrimidines (3b-c). Standard spectrophotometric assays were used to compare the ability of 2a-e and 3b-c to inhibit dihydrofolate reductase (DHFR) from Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium, three examples of opportunistic pathogens to which AIDS patients are highly vulnerable because of their immunocompromised state. For comparison, 13 previously untested 2,4-diamino-6-(substituted benzyl)quinazolines (17a-m) were also evaluated as inhibitors of these enzymes, as well as the enzyme from rat liver. None of the quinazolines or pyridopyrimidines tested was more potent against the P. carinii enzyme than the structurally related reference compound piritrexim (1), and none showed selectivity for the P. carinii enzyme over the rat enzyme. One of the pyridopyrimidines (2c) showed 10-fold selectivity for T. gondii versus rat DHFR, and two of them (2b, 2c) showed selectivity for the M. avium enzyme. However, this gain in species selectivity was achieved at the cost of decreased in potency, as has been noted with many other lipophilic DHFR inhibitors.


Subject(s)
Folic Acid Antagonists/chemical synthesis , Folic Acid Antagonists/pharmacology , Mycobacterium avium/enzymology , Pneumocystis/enzymology , Pyrimidines/chemical synthesis , Pyrimidines/pharmacology , Tetrahydrofolate Dehydrogenase/metabolism , Toxoplasma/enzymology , Animals , Humans , Inhibitory Concentration 50 , Leukemia/metabolism , Liver/enzymology , Rats , Species Specificity , Structure-Activity Relationship , Tumor Cells, Cultured
18.
Med Mycol ; 41(6): 533-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14725329

ABSTRACT

Dihydropteroate synthase gene (DHPS) mutations at codons 55 and 57 have been associated with sulfa/sulfone resistance in Pneumocystis jirovecii strains from patients who previously received prophylaxis. To evaluate the prevalence of these mutations, a portion of P. jirovecii DHPS gene was analysed using PCR combined with restriction fragment length polymorphism (RFLP) analysis in 92 bronchoalveolar fluid samples collected between January 1998 and September 2001 from French patients with pulmonary pneumocystosis (PCP). Seventy-six samples contained the wild-type DHPS genotype (82.6%) and 16 contained a mutant genotype (17.4%). Twelve out of the 16 isolates with a mutant DHPS genotype corresponded to patients who had never received sulfa or sulfone prophylaxis, suggesting that DHPS mutants may be acquired de novo. There was no significant difference in favourable or adverse outcome in PCP caused by the wild or mutant DHPS genotypes (P = 0.34).


Subject(s)
Dihydropteroate Synthase/genetics , Pneumocystis/enzymology , Pneumonia, Pneumocystis/microbiology , DNA, Fungal/analysis , DNA, Fungal/genetics , Dihydropteroate Synthase/metabolism , France/epidemiology , Genotype , Humans , Mutation/genetics , Pneumocystis/genetics , Pneumonia, Pneumocystis/epidemiology , Pneumonia, Pneumocystis/physiopathology , Polymorphism, Restriction Fragment Length , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...